Cite
Ikezaki H, Nomura H, Furusyo N, et al. Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C. Hepatol Res. 2015;46(3):E174-80doi: 10.1111/hepr.12555.
Ikezaki, H., Nomura, H., Furusyo, N., Ogawa, E., Kajiwara, E., Takahashi, K., Kawano, A., Maruyama, T., Tanabe, Y., Satoh, T., Nakamuta, M., Kotoh, K., Azuma, K., Dohmen, K., Shimoda, S., Hayashi, J. (2016). Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology, 46(3), E174-80. https://doi.org/10.1111/hepr.12555
Ikezaki, Hiroaki, et al. "Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,3 (2016): E174-80. doi: https://doi.org/10.1111/hepr.12555
Ikezaki H, Nomura H, Furusyo N, Ogawa E, Kajiwara E, Takahashi K, Kawano A, Maruyama T, Tanabe Y, Satoh T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J. Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C. Hepatol Res. 2016 Mar;46(3):E174-80. doi: 10.1111/hepr.12555. Epub 2015 Sep 02. PMID: 26189962.
Copy
Download .nbib